Australia: an island in a sea of measles

Kirsten M Williamson, Tony Merritt and David N Durrheim
Med J Aust 2020; 213 (3): . || doi: 10.5694/mja2.50650
Published online: 15 June 2020

Combatting the resurgence of measles requires vigilant clinicians and sustained, high level vaccination coverage

At the beginning of 2020, Samoa was in a state of emergency due to a measles outbreak. It resulted in over 5700 cases and over 80 deaths, the majority being in children under 5 years of age.1 There were concurrent outbreaks regionally, in New Zealand, Tonga, American Samoa and Fiji. Globally, there has been a massive resurgence of measles with over 360 000 cases reported to the World Health Organization between 1 January and 31 July 2019 — almost three times the number reported over the same period for 2018. We have also seen the re‐establishment of endemic measles in some countries, such as the United Kingdom, where it was previously eliminated.2

  • 1 Hunter New England Local Health District, Newcastle, NSW
  • 2 Australian National University, Canberra, ACT
  • 3 University of Newcastle, Newcastle, NSW

Competing interests:

No relevant disclosures.

  • 1. United Nations Office for the Coordination of Humanitarian Affairs. Pacific: measles outbreak – Oct 2019. Disaster description – Samoa. Geneva: OCHA, 2020. (viewed May 2020)
  • 2. World Health Organization. Immunisation, vaccine and biologicals. New measles surveillance data from WHO. 12 Aug 2019. Geneva: WHO, 2019. (viewed Feb 2020).
  • 3. National Notifiable Diseases Surveillance System. Number of notifications of measles, received from state and territory health authorities in the period of 1991 to 2019 and year‐to‐date notifications for 2020 (14 May). Canberra: Australian Government Department of Health, 2020. (viewed May 2020).
  • 4. Australian Government Department of Health. Measles: CDNA national guidelines for public health units. Canberra: DoH, 2019. (viewed May 2020).
  • 5. Moss WJ. Measles. Lancet 2017; 390: 2490–2502.
  • 6. Gastañaduy PA, Banerjee E, DeBolt C, et al. Public health responses during measles outbreaks in elimination settings: strategies and challenges. Hum Vaccin Immunother 2018; 14: 2222–2238.
  • 7. Huppatz C, Durrheim DN, Levi C, et al. Etiology of encephalitis in Australia, 1990‐2007. Emerg Infect Dis 2009; 15: 1359–1365.
  • 8. Gibney KB, Attwood LO, Nicholson S, et al. Emergence of attenuated measles illness among IgG‐positive/IgM‐negative measles cases: Victoria, Australia, 2008–2017. Clin Infect Dis 2020; 70: 1060–1067.
  • 9. Sundell N, Dotevall L, Sansone M, et al. Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections. Euro Surveill 2019; 24: 1900114.
  • 10. Cherry JD, Zahn M. Clinical characteristics of measles in previously vaccinated and unvaccinated patients in California. Clin Infect Dis 2018; 67: 1315–1319.
  • 11. Pillsbury A, Quinn H. An assessment of measles vaccine effectiveness, Australia, 2006‐2012. Western Pac Surveill Response J 2015; 6: 43–50.
  • 12. Durrheim DN, Crowcroft NS. The price of delaying measles eradication. Lancet Public Health 2017; 2: e130–e131.
  • 13. Australian Government Department of Health. Measles laboratory case definition. Page last updated 6 Aug 2010. (viewed May 2020).
  • 14. Mercader S, Garcia P, Bellini WJ. Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings. Clin Vaccine Immunol 2012; 19: 1810–1817.
  • 15. Heywood AE, Gidding HF, Riddell MA, et al. Elimination of endemic measles transmission in Australia. Bull World Health Organ 2009; 87: 64–71.
  • 16. Australian Government Department of Health. Immunisation coverage for all children. State and territory coverage rates. Data as at 31 Dec 2019. Canberra: DoH, 2019. (viewed May 2020).
  • 17. Thomas S, Cashman P, Islam F, et al. Tailoring immunisation service delivery in a disadvantaged community in Australia; views of health providers and parents. Vaccine 2018; 36: 2596–2603.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.